retatrutide triple agonist glp-1 gip glucagon phase 2 results Retatrutide, a GIP, and receptor agonist Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon
Pay in 4 interest-free payments of $7.06 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8



























